Lifang Guo
-
- Cancer, Hypoxia, and Metabolism 6
- Cancer-related molecular mechanisms research 3
-
- Angiogenesis and VEGF in Cancer 10
-
- Vascular Tumors and Angiosarcomas 2
-
- Cancer Research and Treatments 3
-
- Vascular Malformations and Hemangiomas 2
-
- Cardiac tumors and thrombi 2
-
- Sarcoma Diagnosis and Treatment 2
- Journals
- Nature Communications (1 paper)Clinical Cancer Research (1 paper)Free Radical Biology and Medicine (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Lifang Guo
24 papers receiving 372 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 136
- Molecular Biology 231
- Immunology and Allergy 20
- Oncology 82
- Otorhinolaryngology 8
Countries citing papers authored by Lifang Guo
This map shows the geographic impact of Lifang Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifang Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifang Guo more than expected).
Fields of papers citing papers by Lifang Guo
This network shows the impact of papers produced by Lifang Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifang Guo. The network helps show where Lifang Guo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lifang Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 24 | |
| 5 | 2023 | 2 | |
| 6 | 2021 | 7 | |
| 7 | 2021 | 5 | |
| 8 | 2020 | 17 | |
| 9 | 2020 | 8 | |
| 10 | 2019 | 1 | |
| 11 | 2019 | 40 | |
| 12 | 2019 | 4 | |
| 13 | 2018 | 4 | |
| 14 | 2015 | 31 | |
| 15 | 2015 | 4 | |
| 16 | 2015 | 12 | |
| 17 | 2014 | 10 | |
| 18 | 2014 | 84 | |
| 19 | 2014 | 21 | |
| 20 | 2014 | 43 |
About Lifang Guo
Lifang Guo is a scholar working on Cancer Research, Biotechnology and Immunology and Allergy, having authored 25 papers that have together received 375 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (10 papers), Cancer, Hypoxia, and Metabolism (6 papers), Cancer Research and Treatments (3 papers), Cancer-related molecular mechanisms research (3 papers), Vascular Tumors and Angiosarcomas (2 papers), Vascular Malformations and Hemangiomas (2 papers), Cardiac tumors and thrombi (2 papers) and Sarcoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (136 citations), Molecular Biology (231 citations) and Immunology and Allergy (20 citations). Lifang Guo has collaborated with scholars based in China and United States. Frequent co-authors include Yan Fu, Nan Song, Lin Jia, Ting He, Feifei Qi, Yongzhang Luo, Shan Wang, Zirui Wan, Yang Chen and Guanghua Liu. Their work appears in journals such as Nature Communications, Clinical Cancer Research and Free Radical Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.